Scientists are to test whether an experimental drug can prevent potentially deadly blood clots associated with Covid-19.

The trial, funded by the British Heart Foundation, will test the theory the clots are caused by a hormone imbalance triggered by coronavirus infection.

It will become one of several drugs currently being trialled to prevent the disease’s worst effects.

A third of hospitalised coronavirus patients develop dangerous blood clots.

The drug, TRV027, works to rebalance hormones involved in blood pressure, water and salt.

Scientists from Imperial College London, involved in the trial, think that when the virus enters the body, it uses an enzyme as a “handle” to enter the cells.

But this disables the enzyme, which plays an important role in balancing the key hormones. When out

Read More At Article Source | Article Attribution